Pegasys TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: peginterferon alfa-2a
Brand name
(ARTG)
: PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringeDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Chronic Hepatitis C (CHC): The combination of PEGASYS and COPEGUS is indicated for the treatment of chronic heptitis C in patients who have received no prior interferon therapy (treatment naive patients) and patients who have failed previous treatment with interferon alfa (pegylated or non-pegylated) alone or in combination therapy with ribavirin. The combination of PEGASYS and COPEGUS is also indicated for the treatment of chronic hepatitis C in patients with clinically stable human immunodeficiency virus (HIV) co-infection who have previously not received interferon therapy. PEGASYS monotherapy is indicated for the for the treatment of chronic heptitis C in treatment naive patients (see Dosage and Administration; Chronic Hepatitis C: Treatment naive patients). Patients must be 18 years of age or older and have compensated liver disease. Chronic Hepatitis B (CHB): PEGASYS is indicated for the treatment of chronic heptitis B in adult patients with evidence of viral replication and liver inflammation and compensated liver disease.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Subcutaneous
- Clear, colourless to light yellow solution, practically free from particles.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Shake
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 4 pre-filled syringes with needles pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient peginterferon alfa-2a
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
